Literature DB >> 8029511

The promise of immunotherapy for tuberculosis.

J L Stanford, J M Grange.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8029511     DOI： 10.1016/0954-6111(94)90166-x

Source DB:  PubMed          Journal:  Respir Med        ISSN： 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  6 in total

1.  Prospects for global health: lessons from tuberculosis.

Authors:  S R Benatar
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 2.  Future directions in the development of new antitubercular drugs. Where do we go from here?

Authors:  W W Yew; C H Chau
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

3.  Current trends in the management of tuberculosis.

Authors:  J M Grange; J L Stanford
Journal:  J R Soc Med       Date:  1994-12       Impact factor: 5.344

Review 4.  Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.

Authors:  Satria A Prabowo; Matthias I Gröschel; Ed D L Schmidt; Alena Skrahina; Traian Mihaescu; Serap Hastürk; Rotislav Mitrofanov; Edita Pimkina; Ildikó Visontai; Bouke de Jong; John L Stanford; Père-Joan Cardona; Stefan H E Kaufmann; Tjip S van der Werf
Journal:  Med Microbiol Immunol       Date:  2012-11-10       Impact factor: 3.402

5.  Role of immunotherapy in the treatment of tuberculosis.

Authors:  K J Murthy; V Vijaya Lakshmi; S Singh
Journal:  Indian J Clin Biochem       Date:  1997-12

6.  An epitope delivery system for use with recombinant mycobacteria.

Authors:  C Hetzel; R Janssen; S J Ely; N M Kristensen; K Bunting; J B Cooper; J R Lamb; D B Young; J E Thole
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.